WO2007052226A2 - Packaging for viewing visually distinct phases of a composition - Google Patents
Packaging for viewing visually distinct phases of a composition Download PDFInfo
- Publication number
- WO2007052226A2 WO2007052226A2 PCT/IB2006/054050 IB2006054050W WO2007052226A2 WO 2007052226 A2 WO2007052226 A2 WO 2007052226A2 IB 2006054050 W IB2006054050 W IB 2006054050W WO 2007052226 A2 WO2007052226 A2 WO 2007052226A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- viewing
- personal care
- visually distinct
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 238000004806 packaging method and process Methods 0.000 title description 5
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000012071 phase Substances 0.000 description 57
- 230000000007 visual effect Effects 0.000 description 24
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- -1 polyethylene terephthalate Polymers 0.000 description 7
- 239000003086 colorant Substances 0.000 description 6
- 239000000834 fixative Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 229920001179 medium density polyethylene Polymers 0.000 description 2
- 239000004701 medium-density polyethylene Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 229960003885 sodium benzoate Drugs 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- KVMUSGMZFRRCAS-UHFFFAOYSA-N sodium;5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)diazenyl]-4h-pyrazole-3-carboxylic acid Chemical compound [Na+].OC(=O)C1=NN(C=2C=CC(=CC=2)S(O)(=O)=O)C(=O)C1N=NC1=CC=C(S(O)(=O)=O)C=C1 KVMUSGMZFRRCAS-UHFFFAOYSA-N 0.000 description 2
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 2
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 239000004149 tartrazine Substances 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AZXGXVQWEUFULR-UHFFFAOYSA-N 2',4',5',7'-tetrabromofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 AZXGXVQWEUFULR-UHFFFAOYSA-N 0.000 description 1
- QAFVCQUYWNQSLJ-UHFFFAOYSA-N 2-(5,5-dimethylhexoxy)ethanol Chemical compound CC(C)(C)CCCCOCCO QAFVCQUYWNQSLJ-UHFFFAOYSA-N 0.000 description 1
- BLDFSDCBQJUWFG-UHFFFAOYSA-N 2-(methylamino)-1,2-diphenylethanol Chemical compound C=1C=CC=CC=1C(NC)C(O)C1=CC=CC=C1 BLDFSDCBQJUWFG-UHFFFAOYSA-N 0.000 description 1
- PWUSHZPXYOALFZ-UHFFFAOYSA-N 3-hydroxy-4-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalene-2-carboxylic acid Chemical compound OC(=O)c1cc2ccccc2c(N=Nc2ccc3ccccc3c2S(O)(=O)=O)c1O PWUSHZPXYOALFZ-UHFFFAOYSA-N 0.000 description 1
- XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- GSEGKBMSKPDICA-UHFFFAOYSA-L barium(2+) 2-[(3-carboxy-2-oxidonaphthalen-1-yl)diazenyl]-5-methylbenzenesulfonate Chemical compound [Ba++].Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C([O-])=O)c(c1)S([O-])(=O)=O GSEGKBMSKPDICA-UHFFFAOYSA-L 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000004064 cosurfactant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- OOYIOIOOWUGAHD-UHFFFAOYSA-L disodium;2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C([O-])C(Br)=C1OC1=C(Br)C([O-])=C(Br)C=C21 OOYIOIOOWUGAHD-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 238000009459 flexible packaging Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000007646 gravure printing Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000005026 oriented polypropylene Substances 0.000 description 1
- 239000004798 oriented polystyrene Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940023735 panthenyl ethyl ether Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical class S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229940096956 ppg-11 stearyl ether Drugs 0.000 description 1
- 229940116987 ppg-3 myristyl ether Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical class SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 229920006352 transparent thermoplastic Polymers 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D23/00—Details of bottles or jars not otherwise provided for
- B65D23/08—Coverings or external coatings
- B65D23/0842—Sheets or tubes applied around the bottle with or without subsequent folding operations
- B65D23/085—Sheets or tubes applied around the bottle with or without subsequent folding operations and glued or otherwise sealed to the bottle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D23/00—Details of bottles or jars not otherwise provided for
- B65D23/08—Coverings or external coatings
- B65D23/0842—Sheets or tubes applied around the bottle with or without subsequent folding operations
- B65D23/0878—Shrunk on the bottle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/54—Inspection openings or windows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B2220/00—Specific aspects of the packaging operation
- B65B2220/14—Adding more than one type of material or article to the same package
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2201/00—Means or constructions for testing or controlling the contents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2203/00—Decoration means, markings, information elements, contents indicators
- B65D2203/02—Labels
Definitions
- the present application relates generally to containers and more particularly to a container that allows viewing of visually distinct phases of a composition.
- compositions have been developed that employ two or more phases packaged in a single container.
- the phases although packaged in physical contact are, at least initially, separate and distinct. It is desirable to allow viewing of at least a portion of a composition having two or more phases, particularly in instances wherein the composition is visually pleasing.
- Previously containers have been proposed to hold personal care compositions having two or more phases.
- the containers may be transparent, which can provide a consumer with the ability to view the composition therein.
- one drawback to these previous containers is that they require that the composition remain substantially stable in order to maintain the desired pleasing aesthetic appearance to the consumer. Therefore a need still exists in the art for a package suitable for containing a personal care composition comprising at least two visually distinct phases which communicates the multi phase nature of the product to the consumer but does not necessarily require long term stability.
- the invention features a container for a personal care composition having at least two visually distinct phases wherein the visually distinct phases can be seen through a portion of the container.
- the container includes a viewing portion that allows for viewing of the visually distinct phases within the container and a covering portion that inhibits viewing of the composition within the container.
- the viewing portion is from about 0.5% to about 70% of the surface area of the package exclusive of any closure. More preferably the viewing portion is from about 0.5% to about 50 % of the surface area of the package exclusive of any closure.
- the viewing portion is completely bounded by the covering portion.
- the viewing and covering portions may be formed by a sleeve or wrap.
- the sleeve may be a shrink sleeve that extends about a periphery of the container.
- the container may have a transparent body.
- the personal care composition may be a multi-phase composition where phases of the composition form the visually distinct phases.
- Fig. 1 is a front view of an embodiment of a container
- Fig. 2 is an exploded front view of the container of Fig. 1
- Fig. 3 A illustrates a back of the container of Fig. 1
- Fig. 3B illustrates a side of the container of Fig. 1
- Fig. 3C illustrates a face of the container of Fig. 1
- Fig. 3D illustrates a side of the container of Fig. 1
- Fig. 4 shows an embodiment of a shrink sleeve removed from the container of Fig. l;
- Fig. 5 is a front view of another embodiment of a container
- Fig. 6 is a front view of another embodiment of a container
- Fig. 7 is a front view of another embodiment of a container
- Fig. 8 is a front view of yet another embodiment of a container
- Fig. 9 is a front view of another embodiment of a container.
- “visually distinct” phases are regions that can be observed by a viewer as distinctly separate regions in contact with one another. Regions may be visually distinct from each other due to, for example, color differences, shape differences, size differences, or a combination of these.
- the term "transparent” refers generally to having the property of transmitting light without appreciable scattering so that visually distinct phases lying beyond are seen. Transparent packaging, or at least a portion thereof, has a percent transmittance of light in the visible wavelengths of between about 50% and about 100%.
- a “visibly clear” composition refers to a composition having a transmission of about 60% or greater, such as about 80% or greater.
- the transmission of a composition is measured using Ultra- Violet/Visible (UV/VIS) Spectrophotometry, which determines the absorption or transmission of UV/VIS light by a sample.
- a light wavelength of 600 nm has been shown to be adequate for characterizing the degree of clarity of personal care compositions.
- the specific instructions associated with the specific spectrophotometer should be followed. In general, the procedure for measuring percent transmittance starts by setting the spectrophotometer to the 600 nm. Then a calibration "blank" is run to calibrate the readout to 100 percent transmittance. The test sample is then placed in a cuvette designed to fit the specific spectrophotometer and the percent transmittance is measured by the spectrophotometer at 600 nm.
- multi-phased or “multi-phase” as used herein, it is meant that at least two phases of a composition occupy separate and distinct physical spaces inside packaging in which they are stored, but are in direct contact with one another (i.e., they are not separated by a barrier).
- multi-phased personal care compositions comprising at least two phases are present within a container as a visually distinct pattern. The pattern results from the mixing or homogenization of the multi-phased composition.
- the patterns include but are not limited to the following examples: striped, marbled, rectilinear, interrupted striped, check, mottled, veined, clustered, speckled, geometric, spotted, ribbons, helical, swirl, arrayed, variegated, textured, grooved, ridged, waved, sinusoidal, spiral, twisted, curved, cycle, streaks, striated, contoured, anisotropic, laced, weave or woven, basket weave, spotted, and tessellated.
- the pattern is selected from the group consisting of striped, geometric, marbled, and combinations thereof.
- the striped pattern may be relatively uniform and even across the dimension of the package.
- the striped pattern may be uneven, i.e. wavy, or may be non-uniform in dimension.
- the striped pattern does not need to necessarily extend across the entire dimension of the package.
- the phases may be various different colors, or include particles, glitter or pearlescence.
- personal care composition refers to compositions that are intended to include only those compositions for topical application to the hair, skin or other regions of a human or animal body.
- a personal care product 10 includes a personal care composition 12 contained within packaging, in this example, container 14.
- Container 14 includes a dispensing part 16 and a receptacle part 18 to form a containing volume for holding the personal care composition 12.
- a closure 15 such as a cap, lid, closable spout, etc. may be connected at the dispensing part 16 to inhibit unintended spillage of the personal care composition from the container 14.
- Container 14, in this example may be referred to as an inverted container in that the dispensing part 16 or closure 15 can also provide a base of the container that can be used to support the container on a surface in an upright, standing position.
- receptacle part 18 (or an additional component connected to the receptacle part) may be used to form the base or an additional base that can be used to support the container 14 in an upright, standing position.
- container 14 includes a discrete visual indication area 20 displaying a visually distinct pattern.
- receptacle part 18 of the container 14 is formed of a transparent material such as a transparent thermoplastic material or transparent glass.
- a shrink sleeve or wrap 22 (shown in part by Fig. 2) envelops at least a portion of the receptacle part 18 by extending about a periphery of the receptacle part as a tube-like flexible sleeve.
- Shrink sleeve or wrap 22 may be made, for example, from a single film of plastic or may be laminated in two or more layers.
- Shrink sleeve or wrap 22 may be a pigmented or transparent glossy film which is printed on or in the case of a laminated film, at least one layer of film may be pigmented or printed by the addition of dyes or pigments before or at the point of extruding the laminate.
- Shrink sleeve or wrap 22 may also be decorated with colors, designs, logos, usage instructions, health and regulatory symbols and warnings, and other written or graphical information. Such decorations may be done by flexo- or gravure-printing, lithography, off-set printing, silk- screening and/or rotary screening.
- One exemplary method, known as reverse printing is to print colors on the inside (i.e., container-facing side) of a label in order to maintain label glossiness.
- the shrink sleeve or wrap 22 is formed by forming the plastic film essentially into a tube, preferably by folding the film back upon itself forming a seam, and cutting the tube to form individual sleeves.
- an area of the transparent receptacle part 18 of the container 14 is obscured or even shielded from view, thus obscuring or even preventing viewing of the composition 12 disposed therein.
- Visual indication area 20 displays a visually distinct pattern that is bounded by preprinted or pigmented covering portion 24 that is translucent or opaque.
- the visual indication area 20 is provided by forming the shrink sleeve 22 having a transparent viewing portion 26 (i.e., a window) that allows for viewing therethrough.
- a transparent film used to form the shrink sleeve or wrap 22 may have the transparent portion 26 that is not printed or pigmented while adjacent portions are.
- the visual indication area 20 is provided by removing (e.g., cutting, stamping, etc.) shrink sleeve or wrap 22 material to form the viewing portion 26 or window therethrough, for example, prior to applying the shrink sleeve or wrap 22 to the container 14.
- the entire film may be preprinted or pigmented prior to applying the shrink sleeve or wrap 22 to the container 14.
- the illustrated container 14 has a face 28, a back 30, sides 32 and 34 extending between the front and the back, a longitudinal axis or centerline 38 and a lateral axis or centerline 40 substantially perpendicular to the longitudinal axis or centerline.
- face 28 may include visually pleasing designs, logos, etc.
- back 30 may include directions, ingredients, etc.
- Visual indication area 20 has a portion disposed at the face 28 of the container 14 and a portion disposed at the side 32 of the container, overlapping a corner 36.
- Visual indication area 20 is offset laterally from the longitudinal centerline 38 and offset longitudinally from the lateral centerline 40 within a lower peripheral quadrant 42. In other embodiments, as will be described below, visual indication area may be located in other quadrants 46, 48, 50 and/or may overlap one or both centerlines 38, 40.
- Viewing portion 26 forming the window is sized and arranged to allow for viewing of the personal care composition 12 disposed in the container 14 through the transparent receptacle part 18.
- Personal care composition 12 includes visually distinct phases 52 and 54 and the viewing portion 26 is sized and arranged to allow for viewing of each of the visually distinct phases 52, 54.
- the viewing portion 26 may be sized and arranged to allow for viewing of only some, but more than one visually distinct phases.
- the viewing portion 26 may be sized and arranged to allow for viewing of all the visually distinct phases.
- Figs. 3A-3D individually illustrate the face 28, back 30 and sides 32, 34 of the container 14. As can be seen by Figs. 3A-3D, at least one of the face 28, back 30 and sides 32, 34 is nearly or completely opaque due to covering portion 24. In the illustrated example, referring particularly to Figs. 3A and 3B, back 30 and side 34 are nearly or completely covered by covering portion 24 of sleeve or wrap 22. In some embodiments, however, back 30 and side 34 may not be nearly or completely covered by covering portion 24. Referring to Figs. 3C and 3D, face 28 and side 32 each include covering portion 24 and viewing portion 26.
- viewing portion 26 of the face 28 may be about 70 percent or less (e.g., about 40 percent or less, about 30 percent or less, about 20 percent or less, about 10 percent or less, about 5 percent or less, between about 0.5 percent and about 70 percent, between about 0.5 percent and about 30 percent, between about 0.5 percent and about 20 percent) of the total surface area of the face while, for example, covering portion 24 covers the remaining surface area.
- viewing portion 26 of the side 32 may be about 70 percent or less (e.g., about 40 percent or less, about 30 percent or less, about 20 percent or less, about 10 percent or less, about 5 percent or less, between about 0.5 percent and about 70 percent, between about 0.5 percent and about 30 percent, between about 0.5 percent and about 20 percent) of the total surface area of the side 32 while, for example, covering portion 24 covers the remaining surface area.
- shrink sleeve or wrap 22 is shown removed from the container 14 after the sleeve or wrap 22 has been shrunk onto the container 14 in a flat, laid out state. As can be seen, a majority of the shrink sleeve or wrap 22 includes the covering portion 24 and a minority of the shrink sleeve includes the viewing portion 26.
- Viewing portion 26 is in the shape of an oval. Any other suitable shape may be used such as polygons (e.g., squares, rectangles, etc.), circles, irregular shapes, etc. Shapes in the form of objects may also be used.
- Shrink sleeve or wrap 22 may be formed by any suitable material. Suitable materials include thermoplastics such as polyvinylchloride (PVC), low, medium or high density polyethylene (LDPE, MDPE, HDPE), modified polyethylene terephthalate (PETG), polyethylene terephthalate (PET), polypropylene (PP) and oriented polypropylene (OPP), polystyrene (PS) and oriented polystyrene (OPS), and mixtures thereof.
- PVC polyvinylchloride
- LDPE low, medium or high density polyethylene
- PETG polyethylene terephthalate
- PET polypropylene
- OPP polypropylene
- OPS polystyrene
- OPS oriented polystyrene
- OPS oriented polystyrene
- the personal care composition 12 includes two or more phases forming the visually distinct phases 52, 54.
- the first phase is in physical and/or intimate contact with the second phase.
- the first phase may be suspended or distributed within or along with the second phase in various patterns, such as, for example, striped, marbled, rectilinear, interrupted striped, check, mottled, veined, clustered, speckled, geometric, spotted, ribbons, helical, swirl, arrayed, variegated, textured, grooved, ridged, waved, sinusoidal, spiral, twisted, curved, cycle, streaks, striated, contoured, anisotropic, laced, weave or woven, basket weave, spotted and tessellated.
- the two or more phases may be physically distinct as well as visually distinct.
- the visually distinct phases may be of a different color, opacity or refractive index, thereby allowing the human eye to distinguish between the phases.
- one phase (or phases) may be visibly clear and the other phase (or phases) may be opaque or visibly not clear.
- an outer phase i.e., the phase contacting the inner wall of the container
- the composition 12 may include visually distinct phases or phases using dyes, pigments, pearlescent agents, lakes, colorants or mixtures thereof.
- Colorants useful according to the present invention may include, for example, Red 30 Low Iron, FD&C Red 40 AL Lake, D&C Red Lake Blend of Lake 27 & Lake 30, FD&C Yellow 5 Al Lake, FD&C Yellow 6 Al Lake, FD&C Yellow 5 Lake, FD&C Blue #1 AL Lake, Kowet Titanium Dioxide, D&C Red 30 Talc Lake, D&C Red 6 Barium Lake, D&C Red 7 Calcium Lake, D&C Red 34 Calcium Lake, D&C Red 30!
- the personal care composition 12 may include, but are not limited to, shampoo, conditioner, antiperspirant, deodorant, hair styling products, cleansers, soaps, bodywash, cosmetics, foundations, lotions, creams, ointments, and hydro-alcoholic solutions.
- the phases may be one or a combination of a cleansing phase, a conditioning phase, a benefit phase, or the like.
- one or more of the phases may also comprise additional components such as conditioning agents such as hydrolyzed collagen with trade name Peptein 2000 available from Hormel, water soluble and water insoluble vitamins such as vitamin A, D, Bl, B2, B6, B 12, C, biotin, vitamin E with trade name Emix-d available from Eisai, panthenol available from Roche, pantothenic acid, panthenyl ethyl ether available from Roche, and their derivatives; hydrolyzed keratin, proteins, plant extracts, and nutrients; emollients such as PPG-3 myristyl ether with trade name Varonic APM available from Goldschmidt, Trimethyl pentanol hydroxyethyl ether, PPG- 11 stearyl ether with trade name Varonic APS available from Goldschmidt, Stearyl heptanoate with trade name Tegosoft SH available from Goldschmidt, Lactil (mixture of Sodium lactate, Sodium PCA, Glycine, Fructos
- yptamine and their salts
- antidandruff agents such as zinc pyrithione, pyridinethione salts, azoles, climbazole, octopirox, salicylic acid, selenium sulfide, particulate sulfur and mixtures thereof.
- Viewing portion 26 placement and size can allow for selective viewing of the visually distinct phases 52 and 54, while inhibiting viewing of regions of the composition 12 where mixing may have occurred (e.g., due to shipping, handling, dispensing, etc.). This can be accomplished by locating the viewing portion 26 at a location where there is a lower probability of region or phase mixing. Additionally, in some embodiments, the placement of the visual indication area 20 can allow for viewing of the personal care composition 12 with the container 14 in different orientations, for example, facing forward with face 28 oriented toward the consumer and sideways with the side 32 facing toward the consumer.
- Fig. 5 shows an embodiment where the visual indication area 20 is located in quadrant 48 and overlapping the lateral centerline 40.
- Viewing portion 26 formed by sleeve or wrap 22 has a relatively circular contour and is sized to allow for viewing of the visually distinct phases 52 and 54.
- the visual indication area 20 may be located in multiple quadrants 42, 46, 48, 50.
- Viewing portion 26 has a relatively oval contour that extends over lateral centerline 40 to locate the visual indication area 20 in quadrants 46 and 50.
- Figs. 5 and 6 show visual indication areas that extend along the face 28 and the side 32
- Fig. 7 shows an embodiment having a visual indication area 20 that is disposed entirely on face 28. Other configurations are possible.
- visual indication area 20 may be located at any or all of face 28, back 30, and sides 32, 34.
- any other suitable sleeves, wraps, etc. can be utilized.
- the sleeve or wrap may be formed of any suitable material such as paper (e.g., weighted paper), cardboard, foil, corrugated board, carton, or thermoplastic. Paper or cardboard can allow the total weight of plastic in the container 14 to be minimized and allow the sleeve to be easily separated from the container, whereas a plastic sleeve may eliminate any need to separate the sleeve from the container prior to recycling.
- the sleeve or wrap may be wrapped around the container and glued into position or the sleeve or wrap may have an adhesive backing suitable to adhere the wrap or sleeve to the container.
- the sleeve may be fixed by heat shrinking or stretch wrapping.
- the viewing portion 26 should be sized and arranged such that after the sleeve has been shrunk, the viewing portion allows for viewing of the visually distinct phases as described above.
- the sleeve or wrap covers at least about 30 percent of the outer surface of the container, such as at least about 50 percent, such as at least about 70 percent, such as at least about 80 percent of the outer surface of the container.
- FIG. 8 shows a round bottle 60 having a top 62, a base 64 and a cylindrical body 66.
- Visual indication area 20 is disposed on the body 66 between the top 62 and the base 64.
- Visual indication area 20 can be formed as described above using transparent cylindrical body 66, sleeve or wrap 22, viewing portion 26 and covering portion 24.
- Other exemplary container types include cartons, tubes, flexible packaging, jars, compacts, multi-component assemblies (e.g., deodorants, multi-chamber packages), positive displacement pumps, pressurized canisters, blister packs, etc.
- a product may include a visual indication area 70 that is formed using a preprinted film 72.
- the visual indication area 70 may be formed by a preprinted portion 78 of the sleeve or wrap 22 that includes preprinted and visually distinct phases 74 and 76.
- the preprinted portion 78 may be semi-transparent or opaque.
- visual indication area 70 may be formed using the container itself, for example, without use of any sleeve or wrap.
- only a portion of the receptacle part 18 or body 66 may be transparent to provide viewing portion 26 and allow for viewing of the composition disposed therein while other portions of the receptacle part 18 or body 66 are opaque or translucent to provide the covering portion 24.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008536201A JP2009512600A (ja) | 2005-11-01 | 2006-11-01 | 組成物の視覚的に異なる相を見るための包装 |
EP06821283A EP1945524A2 (en) | 2005-11-01 | 2006-11-01 | Packaging for viewing visually distinct phases of a composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73242205P | 2005-11-01 | 2005-11-01 | |
US60/732,422 | 2005-11-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007052226A2 true WO2007052226A2 (en) | 2007-05-10 |
WO2007052226A3 WO2007052226A3 (en) | 2007-10-11 |
Family
ID=38001171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/054050 WO2007052226A2 (en) | 2005-11-01 | 2006-11-01 | Packaging for viewing visually distinct phases of a composition |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070095721A1 (ja) |
EP (1) | EP1945524A2 (ja) |
JP (1) | JP2009512600A (ja) |
CN (1) | CN101300175A (ja) |
WO (1) | WO2007052226A2 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009077427A1 (en) * | 2007-12-18 | 2009-06-25 | Unilever Plc | Multi-coloured laundry product |
WO2010063582A1 (en) * | 2008-12-04 | 2010-06-10 | Unilever Plc | Multi-coloured laundry products |
WO2010069799A1 (en) * | 2008-12-18 | 2010-06-24 | Unilever Plc | A flowable laundry composition and packaging therefor |
WO2011066262A1 (en) * | 2009-11-25 | 2011-06-03 | Danny Lee Haile | Package for colored products |
AU2013273681B2 (en) * | 2009-11-25 | 2015-12-03 | Danny Lee Haile | Package for coloured products |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349300B2 (en) | 2007-04-19 | 2013-01-08 | The Procter & Gamble Company | Personal care compositions containing at least two cationic polymers and an anionic surfactant |
US8360113B2 (en) * | 2008-09-18 | 2013-01-29 | Advantus, Corp. | Multi-colored adhesive with opalescent and metallic colored particles and method of making same |
FR2947251B1 (fr) * | 2009-06-30 | 2012-11-16 | Sleever Int | Enveloppe d'emballage et de protection d'un conteneur, constituee par un manchon en matiere plastique thermoretractable |
US9776764B2 (en) * | 2010-09-30 | 2017-10-03 | Tetra Laval Holdings & Finance S.A. | Packaging container, and blank usable in the production of such a packaging container |
EP2840929A1 (en) * | 2012-04-27 | 2015-03-04 | The Procter & Gamble Company | Applicator assembly for applying a composition |
US9688434B2 (en) * | 2012-08-17 | 2017-06-27 | Archon Pharmaceutical Consulting Llc | System for compounding and packaging ready to reconstitute ophthalmic drug powders to a solution or to a suspension for administration to an eye of patient |
CN105188850A (zh) | 2013-05-16 | 2015-12-23 | 宝洁公司 | 毛发增稠组合物及使用方法 |
US9371158B2 (en) | 2014-06-25 | 2016-06-21 | The Procter & Gamble Company | Liquid laundry product having a window for viewing |
CN112261931B (zh) | 2018-06-05 | 2023-12-08 | 宝洁公司 | 透明清洁组合物 |
CN112888636B (zh) * | 2018-10-31 | 2023-02-03 | 宝洁公司 | 具有开孔收缩套管的容器和相关方法 |
JP7218059B2 (ja) * | 2019-03-28 | 2023-02-06 | 株式会社吉野工業所 | シュリンクフィルム付き容器及びその製造方法 |
US11896689B2 (en) | 2019-06-28 | 2024-02-13 | The Procter & Gamble Company | Method of making a clear personal care comprising microcapsules |
CN216735268U (zh) | 2020-02-14 | 2022-06-14 | 宝洁公司 | 包装和泵式分配器 |
US12053130B2 (en) | 2021-02-12 | 2024-08-06 | The Procter & Gamble Company | Container containing a shampoo composition with an aesthetic design formed by bubbles |
US11633072B2 (en) | 2021-02-12 | 2023-04-25 | The Procter & Gamble Company | Multi-phase shampoo composition with an aesthetic design |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB241007A (en) * | 1924-10-11 | 1925-10-15 | G & J W Hawksley Ltd | Improvements in or relating to drinking flasks and similar receptacles |
FR1423066A (fr) * | 1964-11-19 | 1966-01-03 | Dispositif pour l'habillage décoratif de récipients en matériau translucide, logeant des liquides transparents | |
JPH08324641A (ja) * | 1995-05-29 | 1996-12-10 | Yoshino Kogyosho Co Ltd | 液体収納容器 |
US20020010110A1 (en) * | 2000-03-20 | 2002-01-24 | Christine Hayward | Extrudable multiphase composition comprising a lamellar phase and an isotropic phase |
WO2002076834A1 (en) * | 2001-03-27 | 2002-10-03 | Stephen Key Design, Llc | System and method for a rotatable sleeve device |
WO2002103659A1 (en) * | 2001-06-15 | 2002-12-27 | Pechiney Emballage Flexible Europe | Container with windowed label |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4227615A (en) * | 1979-05-02 | 1980-10-14 | Flick Gervase M | Medicine container |
US5392947A (en) * | 1993-10-29 | 1995-02-28 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dental mouthwash product |
US6419902B1 (en) * | 1995-12-11 | 2002-07-16 | Howard W. Wright | Color changing toothpaste |
US5785178A (en) * | 1996-11-04 | 1998-07-28 | Minnesota Mining And Manufacturing Co. | Packaged photocurable composition |
JPH1149174A (ja) * | 1997-07-29 | 1999-02-23 | Earth Chem Corp Ltd | 中空容器 |
US6126923A (en) * | 1998-12-11 | 2000-10-03 | Colgate-Palmolive Company | Magically appearing striped dentifrice |
JP2002337878A (ja) * | 2001-05-07 | 2002-11-27 | Abdul Karim Abdul Razzaq | のぞき窓のある曇りビンおよびその製造方法 |
US20050143269A1 (en) * | 2003-12-24 | 2005-06-30 | Wei Karl S. | Multi-phase personal cleansing compositions comprising a lathering cleansing phase and a non-lathering structured aqueous phase |
ES2326181T3 (es) * | 2004-06-14 | 2009-10-02 | THE PROCTER & GAMBLE COMPANY | Envase para productos de higiene personal que comprende una etiqueta termoencogible. |
-
2006
- 2006-11-01 JP JP2008536201A patent/JP2009512600A/ja active Pending
- 2006-11-01 EP EP06821283A patent/EP1945524A2/en not_active Withdrawn
- 2006-11-01 CN CN200680040852.7A patent/CN101300175A/zh active Pending
- 2006-11-01 WO PCT/IB2006/054050 patent/WO2007052226A2/en active Application Filing
- 2006-11-01 US US11/591,116 patent/US20070095721A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB241007A (en) * | 1924-10-11 | 1925-10-15 | G & J W Hawksley Ltd | Improvements in or relating to drinking flasks and similar receptacles |
FR1423066A (fr) * | 1964-11-19 | 1966-01-03 | Dispositif pour l'habillage décoratif de récipients en matériau translucide, logeant des liquides transparents | |
JPH08324641A (ja) * | 1995-05-29 | 1996-12-10 | Yoshino Kogyosho Co Ltd | 液体収納容器 |
US20020010110A1 (en) * | 2000-03-20 | 2002-01-24 | Christine Hayward | Extrudable multiphase composition comprising a lamellar phase and an isotropic phase |
WO2002076834A1 (en) * | 2001-03-27 | 2002-10-03 | Stephen Key Design, Llc | System and method for a rotatable sleeve device |
WO2002103659A1 (en) * | 2001-06-15 | 2002-12-27 | Pechiney Emballage Flexible Europe | Container with windowed label |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009077427A1 (en) * | 2007-12-18 | 2009-06-25 | Unilever Plc | Multi-coloured laundry product |
WO2010063582A1 (en) * | 2008-12-04 | 2010-06-10 | Unilever Plc | Multi-coloured laundry products |
WO2010069799A1 (en) * | 2008-12-18 | 2010-06-24 | Unilever Plc | A flowable laundry composition and packaging therefor |
WO2011066262A1 (en) * | 2009-11-25 | 2011-06-03 | Danny Lee Haile | Package for colored products |
US8528739B2 (en) | 2009-11-25 | 2013-09-10 | Danny Lee Haile | Package for colored products |
AU2013273681B2 (en) * | 2009-11-25 | 2015-12-03 | Danny Lee Haile | Package for coloured products |
Also Published As
Publication number | Publication date |
---|---|
US20070095721A1 (en) | 2007-05-03 |
EP1945524A2 (en) | 2008-07-23 |
JP2009512600A (ja) | 2009-03-26 |
CN101300175A (zh) | 2008-11-05 |
WO2007052226A3 (en) | 2007-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070095721A1 (en) | Packaging for viewing visually distinct phases of composition | |
US8523016B2 (en) | Dispensing container | |
US10040581B2 (en) | Methods of making flexible containers | |
US6405867B1 (en) | Package for a suncream | |
WO2007091224A1 (en) | Clamshell package for holding and displaying consumer products | |
EP1937564B1 (en) | Transparent or translucent filled package exhibiting a colored appearance | |
JP2009501151A (ja) | 少なくとも2つの相を含むパーソナルケア組成物の壁効果を最小化することにより改善された安定性プロファイル | |
JP6516167B2 (ja) | 改善された視覚性を有するブリスター包装体 | |
US20080245677A1 (en) | Oral Care Package | |
JP6753595B2 (ja) | 容器装着パネルとこれを用いた詰合せセット | |
JP2017171356A (ja) | 包装体の製造方法、及び包装体 | |
KR102255708B1 (ko) | 패드형 화장품 | |
US20230294887A1 (en) | Cap of a package suitable for storing personal health care products | |
ITTO20030053U1 (it) | Unita' per il dosaggio giornaliero di melatonina. | |
US20230294886A1 (en) | Cap of a package suitable for storing personal health care products | |
AU734855B2 (en) | Package for a suncream | |
JP2002337928A (ja) | 化粧プランパッケージ | |
ITVR20030023U1 (it) | Perfezionamento ai mezzi di congiunzione di contenitori a flacone in particolare per prodotti farmaceutici, cosmetici o simili. | |
KR20200000461U (ko) | 화장품 포장 용기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680040852.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006821283 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008536201 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/005510 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006821283 Country of ref document: EP |